Description
Despite extensive molecular characterization forming the basis of WHO 2021 classification, targeted therapies remain largely ineffective except for BRAF alterations. This contradiction between molecular understanding and therapeutic success represents a critical translational gap in glioma treatment.
Gap type: contradiction Source paper: Primary brain tumours in adults. (None, None, PMID:37738997)